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InflammationGrape pomace is an agro-industrial residue produced worldwide. The purpose of this study was to iden-
tify and quantify the main phenolics present in an hydroalcohlic extract of a Merlot grape pomace and to
investigate its effect on the oxidative and inflammatory states of adjuvant-induced arthritic rats. Daily
doses of 250 mg of the extract per kg body weight were administered during 23 days. Several oxidative
stress indicators in arthritic rats were maintained at their normal or closely normal levels in the plasma,
liver and brain by the treatment. Additionally, the grape pomace also showed significant anti-
inflammatory effects. From the 25 phenolics identified in the grape pomace extract the most abundant
ones were catechin and catechin derivatives, which are possibly the most important antioxidant agents.
The results suggest a potential applicability of the Merlot grape pomace hydroalcoholic extract in the
improvement of the oxidative and inflammatory states in arthritic patients.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Rheumatoid arthritis (RA) is an autoimmune disease character-
ized by chronic inflammation of the joints (the synovial mem-
brane) and subsequent destruction of cartilage and bone. The
disease involves well known immunological events, such as partic-
ipation of T cells, B cells, macrophages and pro-inflammatory
cytokines (Stolina et al., 2009). The progression of the disease is
also accompanied by an increased oxidative stress in the lesion
sites (Seven, Güzel, Aslan, & Hamuryudan, 2008). Furthermore, as
a multisystem disease, rheumatoid arthritis also affects organs
such as liver, heart, brain and vascular tissue. The liver of rats with
adjuvant-induced arthritis, for example, presents increased rates of
oxygen uptake, inhibition of gluconeogenesis and stimulation ofglycolysis, alterations in the urea cycle and modifications in cal-
cium homeostasis (Fedatto-Jr et al., 1999, 2000; Utsunomiya,
Scaliante, Bracht, & Ishii-Iwamoto, 2013; Yassuda-Filho et al.,
2003). Substantial oxidative stress and molecular damage has also
been demonstrated to occur in the plasma, liver, brain and heart of
both arthritic patients (Mateen, Moin, Khan, Zafar, & Fatima, 2016)
and experimental animals (Bracht et al., 2016; Comar et al., 2013;
Schubert et al., 2016; Wendt et al., 2015).
There has been a systematic search for natural products able to
attenuate the deleterious effects of arthritis and other inflamma-
tory diseases. With this purpose several preparations rich in
antioxidant flavonoids or purified flavonoids have been investi-
gated (Somasundaram & Oommen, 2013). Clereodendrum inerme,
for example, exerts anti-inflammatory actions that have been
attributed mainly to its flavonoid constituents (Khanam et al.,
2014; Somasundaram & Oommen, 2013). Tamarindus indica seed
extracts, rich in procyanidins, show protective efficacy against
arthritis-associated oxidative damage (Sundaram et al., 2014).
Another example is green tea, which has been shown to inhibit
the inflammatory responses and the development of arthritis in
animal model studies (Singh, Akhtar, & Haqqui, 2010) and also to
improve in a significant way the oxidative state of arthritic rats
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catechins (polyphenolics), which are important constituents of
green-tea.
Within the perspective of an implemented use of flavonoids in
food supplements, it could be of interest to use abundant and rel-
atively inexpensive sources of these compounds. One such source
could be the most important by-product of the wine industry,
namely, grape pomace (Fontana, Antoniolli, & Bottini, 2013;
Hogan, Canning, Sun, Sun, & Zhou, 2010; Ky & Teissedre, 2015;
Ribeiro et al., 2015; Souad, Faten, Emad, Emad, & Doha, 2014).
The latter consists mainly of skins, but also of seeds, pedicels and
peduncles and the pulp remaining after pressing the grapes. Grape
pomace is an agro-industrial residue produced worldwide and
already employed for animal feed or as a fertilizer. Grapes contain
many different phenolic compounds distributed in pulp, seeds and
skin. These compounds are the main determinants of colour, taste,
mouth feel and oxidation (Shi, Yu, Pohorly, & Kakuda, 2003). Dur-
ing the winemaking process, a fraction of the phenolic compounds
is transferred to the wine, but a significant proportion still remains
in the residues, especially in the grape pomace (Iora et al., 2015;
Ribeiro et al., 2015; Shi et al., 2003). It is, thus, of interest to char-
acterize and quantify the phenolics and biological effects of grape
pomaces within the perspective of their future use in formulations
of medicinal foods.
The presence of polyphenolics strongly suggests that grape
pomace could be effective against oxidative stress that accompanies
arthritis in a way similar to that observed for green tea extracts
(Gonçalves et al., 2015). It is also of interest to know if the prepara-
tion exerts anti-inflammatory effects. For this reason, we decided
to investigate the action of a hydroalcoholic extract of a grape
pomace of the Merlot variety on several parameters in rats with
adjuvant-induced arthritis. The latter is an experimental immuno-
pathology that presents similarities to human rheumatoid arthritis:
synovial hyperplasia, systemic inflammation, cachexia, and high
levels of plasma pro-inflammatory cytokines and lesion sites
(Bendele et al., 1999; Szekanecz et al., 2000). In order to support
our conclusions in molecular terms, an exhaustive screening of the
Merlot grape pomace for its content in flavonoids and related com-
pounds was also done. The results obtained in the latter procedures
should be helpful in identifying themost probable active principles.
At least to our knowledge, this is the first study analyzing in detail
effects of a grape pomace extract under in vivo conditions.2. Material and methods
2.1. Chemicals
Acetonitrile (99.9%) was of HPLC grade from Fisher Scientific
(Lisbon, Portugal). Phenolic standards were from Extrasynthèse
(Genay, France). Ethanol and all other chemicals were of analytical
grade and purchased from common sources. Water was treated in
a Milli-Q water purification system (TGI Pure Water Systems,
Greenville, SC, USA). Dinitrophenylhydrazine,2070-dichloro-fluores
cein diacetate, oxidized dichloro-fluorescein, 1,10,3,30-tetrae
thoxy-propane, horse-radish peroxidase, o-phthal-aldehyde,
reduced glutathione (GSH), oxidized glutathione (GSSG), glu-
tathione reductase, 2,2-azinobis 3-ethyl-benzothiazoline-6-sulfo
nate (ABTS), Freund’s adjuvant, 5,5-dithiobis 2-nitrobenzoic acid
and formic acid were purchased from Sigma-Aldrich (St. Louis,
MO, USA). All other chemicals were of analytical grade.2.2. Preparation of the Merlot grape pomace extract
Samples of grape pomace from Vitis vinifera of the Merlot vari-
ety, were obtained from companies located in the Paraná State,Brazil. The samples were by-products of the winemaking process,
obtained after the grapes had been pressed. Once in the laboratory,
the Merlot grape pomace sample was dried in a convection oven
(Marconi MA 035, Brazil) at 80 C for 36 h. The dried residues were
milled, stored in polyethylene film bags packed under vacuum and
stored at 20 C until use (Ribeiro et al., 2015).
TheMerlot grapepomace extractswere preparedusing amixture
of 40% ethanol and 60% distilled water (Ribeiro et al., 2015). Extrac-
tionwas done with a solute/solvent ratio of 1:50 (m/v). The suspen-
sions were shaken in a rotary shaker for 24 h at 100 rpm and at a
temperature of 25 C. After this period of time themixture was cen-
trifuged at 3500g for 25 min. Ethanol was eliminated with a rotary
evaporator and the aqueous solution was lyophilized and stored in
a freezer until use (Haminiuk, Plata-Oviedo, Mattos, Carpes, &
Branco, 2014; Ribeiro et al., 2015). One gram dried andmilled grape
pomace resulted in 130 mg lyophilized material (13%).
2.3. Animals and treatment
Male Holtzman rats were fed ad libitum with a standard labora-
tory diet (Nuvilab, Colombo, Brazil) and maintained on a regulated
light dark cycle. For the induction of arthritis, animals weighing
180–210 g were injected in the left hind paw with 0.1 mL of Fre-
und’s complete adjuvant (heat-inactivated Mycobacterium tubercu-
losis, derived from the human strain H37Rv), suspended in mineral
oil at a concentration of 0.5% (w/v) (Pearson &Wood, 1963). Rats of
similar weights were injected with mineral oil and served as con-
trols. All experiments of adjuvant arthritis induction were done in
accordance with the world-wide accepted ethical guidelines for
animal experimentation and previously approved by the Ethics
Committee for Animal Experimentation of the University of Mar-
ingá (Protocol n 8119260115-CEUA-UEM).
For evaluating the effects of the grape pomace extract on the
oxidative status of arthritic rats, the animals were divided into 4
groups (6 rats each): (1) group I were healthy animals (controls);
(2) group IIwere healthy animals treatedwith grape pomace extract
(treated controls); (3) group III were the arthritic rats;(4) group IV
comprised the arthritic rats treated with the grape pomace extract
(treated arthritic rats). Treatment of the arthritic rats consisted in
the administration of the grape pomace extract during 5 days prior
to the induction of arthritis and during additional 18 days after ini-
tiating the induction. The daily doses were 250 mg extract per kg
body weight. This dose was established based on previous experi-
ments with green tea extracts (Gonçalves et al., 2015). The treated
controls received the same doses during 23 days. Non treated ani-
mals, healthy or arthritic, received distilled water for 23 days.
Fig. 1A inAppendixAoffers a schematic viewof themainexperimen-
tal designwith emphasis on the induction of arthritis, grape pomace
treatment and evaluations. The numbers in Fig. 1A correspond to the
four experimental groups mentioned above.
For evaluating the anti-inflammatory activity of the grape
pomace extracts, rats were divided into 4 groups (6 animals each):
(1) healthy animals (controls); (2) arthritic rats; (3) arthritic rats
treated with ibuprofen; and (4) arthriitic rats treated with the
grape pomace extract. Treatment of the arthritic rats consisted in
the administration of ibuprofen or grape pomace extract during
5 days prior to the induction of arthritis and during additional
18 days after initiating the induction. The daily doses were
35 mg/kg for ibuprofen treatment and 250 mg extract/kg for the
grape pomace treatment. Non-treated animals, healthy or arthritic,
received distilled water for 23 days.
2.4. Preparation of liver and brain homogenates
After 18 h of fasting, the rats were decapitated, the brain and the
liver were immediately removed, freeze-clamped, and stored in
Fig. 1. Treatment of normal and arthritic rats with the grape pomace extract: effects on plasmatic oxidative stress indicators. The plasma samples were obtained and
processed as described in Section 2. Values represent the mean ± standard error of the mean of 6 animals for each experimental condition. Columns labeled with the same
symbol on each graph do not differ statistically from each other (p  0.05) according to one-way ANOVA followed by Student-Newman-Keuls post hoc testing. Legends: MPO,
myelo-peroxidase activity; PC, protein carbonyls; FRAP, ferric ion antioxidant reducing power.
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van Potter homogenizer with 10 volumes of ice-cold 0.1 M potas-
sium phosphate buffer (pH 7.4) and aliquots were separated for
use as total homogenates. The remaining homogenates were cen-
trifuged at 11,000g during 15 min and the supernatants separated
as the soluble fractions of the homogenates (Comar et al., 2013;
Gonçalves et al., 2015; Wendt et al., 2015). Protein concentration
wasmeasuredwith the Folin-Ciocalteu reagent, using bovine serum
albumin as a standard (Lowry, Rosebrough, Farr, & Randall, 1951).
2.5. Blood collection and plasma preparation
Rats fasted for 18 h were anesthetized with intraperitoneal
injection of sodium pentobarbital (50 mg/kg) and the blood was
collected by puncturing the inferior vena cava after laparotomy
and transferring it into tubes containing anticoagulant. The sam-
ples were centrifuged at 1000g for 10 min to separate the plasma
fraction (Bracht et al., 2016).
2.6. Reactive oxygen species and protein carbonyls
Reactive oxygen species were assessed in the homogenate
supernatants. The total ROS content was quantified via the 20,70-dichlorofluorescein-diacetate (DCFH-DA) assay (Siqueira,
Fochesatto, da Silva-Torres, Dalmaz, & Alexandre-Netto, 2005).
The formation of DCF was measured immediately after stopping
the reaction on ice with a spectrofluorimeter RF-5301 (Shimadzu)
in which the excitation and emission wavelengths were set at 504
and 529 nm, respectively. A standard curve with oxidized dichlo-
rofluorescein (DCF) was used to express the results as nmol per
mg of protein.
The contents in protein carbonyl groups were measured
spectrophotometrically in the liver and brain homogenates and
in the plasma using 2,4-dinitrophenylhydrazine (DNPH)
(e370 = 22  103 M1 cm1) and the values were expressed as nmol
per mg protein (Levine et al., 1990).2.7. Oxidative state indicators and antioxidant capacity
Reduced (GSH) and oxidized glutathione (GSSG) were measured
in the total homogenate. The GSH and GSSG contents were mea-
sured spectrofluorimetrically (excitation 350 nm and emission
420 nm) by means of the o-phytalaldehyde (OPT) assay as
described previously (Hissin & Hilf, 1976). The fluorescence was
estimated as GSH. For the GSSG assay, the sample was previously
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with a mixture containing 1 M NaOH and 0.4 lM phthalaldehyde
to detect the fluorescence. The results were calculated using a
standard curve prepared with GSH or GSSG and the values were
expressed as nmol per mg protein.
The reduced protein thiol groups in the plasma were deter-
mined using the reaction with 5,50-dithiobis 2-nitrobenzoic acid
(DTNB) (Sedlak & Lindsay, 1968). The reaction product was mea-
sured spectrophotometrically at 412 nm and the molar extinction
coefficient of 1.36  104 M1 cm1 was used to express the results
as nmol per mg protein.
The antioxidant capacity of the plasma was estimated as the
ferric ion antioxidant reducing power (FRAP) (Benzie & Strain,
1996). The FRAP reagent contained (final concentrations):
0.83 mM 2,4,6[2-pyridyl]-s-triazine (TPTZ), 1.67 mM FeCl36H2O
and 250 mM acetate buffer at pH 3.6. Plasma was added for a final
dilution of 34-fold. The temperature of the assay was 37 C and the
reaction was monitored for up to 30 min at 595 nm. The standard
curve was prepared with Trolox (6-hydroxy-2,5,7,8-tetramethyl
chroman-2-carboxylic acid) and the activity was expressed as mmol
Trolox equivalents per mL plasma.
2.8. Enzyme assays
Antioxidant enzymatic activities were assessed in the homoge-
nate supernatant. The catalase (CAT) activity was estimated by
measuring changes in absorbance at 240 nm using H2O2 as sub-
strate and expressed as lmol min1 (mg protein)1 (Aebi, 1974).
The superoxide dismutase (SOD) activity was estimated by its
capacity of inhibiting the pyrogallol autoxidation in alkaline med-
ium. The latter was measured at 420 nm (Marklund & Marklund,
1974). One SOD unit was considered the quantity of enzyme that
was able to promote 50% inhibition and the results were expressed
as units per mg protein.
The myeloperoxidase activity (MPO) was determined by the o-
dianisidine dihydrochloride-H2O2 method (Bradley, Priebat,
Christensen, & Rothstein, 1982). The plasma samples (30 mL) were
added to 900 mL of the reaction mixture containing 50 mM phos-
phate buffer pH 6.0, 0.167 mg/mL o-dianisidine-dihydrochloride
and 0.0005% hydrogen peroxide. The change in absorbance at
460 nm was measured for 1 min. One unit of MPO activity was
defined as the amount of enzyme degrading one micromole of per-
oxide per minute at 25 C.
2.9. Determination of the number of leukocytes recruited in the
femoro-tibial joint cavity
The determination of the number of leukocytes recruited in the
femoro-tibial joint cavity of the legs (injected and not injected) of
arthritic rats was done on day 18 after induction of arthritis. The
rats were euthanized and the femoro-tibial joints were exposed
by surgical sectioning of the patellar tendon. Next, the joint cavity
was washed with 40 mL of a buffered saline solution containing
EDTA. May-Grünwald-Giemsa staining was used to differentiate
and count polymorpho-nuclear and mononuclear leukocytes.
2.10. Paw edema
The inflammatory response induced by Freund’s complete adju-
vant was evaluated in the hind paws of arthritic rats on days 0, 1, 3,
6, 9, 13, 15, 17 and 18. The volume of the injected and contralateral
paw was assessed with a plethysmograph (Ugo Basile), according
to the technique described by Winder, Max, and Been (1957). The
result was expressed in terms of the increase in paw volume rela-
tive to the initial volume.2.11. Arthritic lesions score
The evaluation of the arthritic lesion scores (in the ears, front
legs and tail) was started on the 10th day and continued until
the end of the experiment on day 18. The lesions were evaluated
through the numerical grading system proposed by Rosenthale
(1970), in which points are attributed for each of the following
events: (+1) for nodules on the tail; (+1 or +2) for nodules appear-
ing in one or both ears and (+1 or +2) for swelling of one or both
forelimbs. The severity of the injury was graded from zero to 5,
zero indicating no injury.
2.12. Phenolic profile of the Merlot grape pomace extract
The phenolic profile was determined using the lyophilized
extracts, re-dissolved in an ethanol:water (40:60, v/v) mixture,
by LC-DAD-ESI/MSn (Dionex Ultimate 3000 UPLC, Hermo Scien-
tific, San Jose, CA, USA).
2.12.1. Non-anthocyanin compounds
These compounds were separated and identified as previously
described by Bessada, Barreira, Barros, Ferreira, and Oliveira
(2016). Double online detection was performed using a DAD (280
and 370 nm used as preferred wavelengths) and a mass spectrom-
eter (MS) connected to the HPLC system via the DAD cell outlet.
The MS detection was performed in negative mode, using a Linear
Ion Trap LTQ XL mass spectrometer (Thermo Finnigan, San Jose, CA,
USA) equipped with an ESI source.
2.12.2. Anthocyanin compounds
Chromatographic separation was achieved with a Waters
Spherisorb S3 ODS-2 C18 (3 lm, 4.6 mm  150 mm, Waters, Mil-
ford, MA, USA) column working at 35 C. The solvents used were:
(A) 0.1% trifluoroacetic acid (TFA) in water, (B) acetonitrile. The
gradient elution followed these parameters: 10% B for 3 min, from
10 to 15% B for 12 min, 15% B for 5 min, from 15 to 18% B for 5 min,
from 18 to 30% B for 20 min, from 30 to 35% B for 5 min, and from
35 to 10% B for 10 min. The resulting total run time was 60 min,
followed by column reconditioning of 10 min, using a flow rate
of 0.5 mL/min. Double online detection was carried out in the
DAD using 520 nm as the preferred wavelength and in a mass spec-
trometer (MS) connected to HPLC system via the DAD cell outlet.
MS detection was performed in positive mode, using a Linear Ion
Trap LTQ XL mass spectrometer (Thermo Finnigan, San Jose, CA,
USA) equipped with an ESI source. Nitrogen served as the sheath
gas (50 psi); the system was operated with a spray voltage of
4.8 kV, a source temperature of 320 C, a capillary voltage of 14
V. The tube lens offset was kept at a voltage of 75 V. The full scan
covered the mass range fromm/z 100 to 1500. The collision energy
used was 20 (arbitrary units). Data acquisition was carried out
with Xcalibur data system (Thermo Finnigan, San Jose, CA, USA).
2.12.3. Identification and quantification
The identification of the phenolic compounds (non-anthocyanin
and anthocyanin compounds) was performed using standard com-
pounds, when available, by comparing their retention times, UV–
vis and mass spectra; and also, comparing the obtained informa-
tion with available data reported in the literature giving a tentative
identification. For quantitative analysis, a calibration curve for each
available phenolic standard was constructed based on the UV sig-
nal. For the identified phenolic compounds for which a commercial
standard was not available, the quantification was performed
through the calibration curve of the most similar available stan-
dard. Compounds 1, 3 and 8 were quantified using gallic acid
(y = 208,604x + 173,056; R2 = 0.999), compounds 2, 4–7 and 9–12
were quantified using (+)-catechin (y = 84,950x  23,200;
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R2 = 0.999), compounds 14–20 with quercetin-3-O-glucoside
(y = 34,843x  160,173; R2 = 0.999) and compounds 21–25 with
peonidin-3-O-glucoside (y = 122,417x  447,974; R2 = 0.999). The
results were expressed as mg/g of extract.2.13. Statistical analysis
The error parameters presented in graphs and tables are stan-
dard errors of the means. Statistical analysis was done by means
of the GraphPad Prism Software (version 5.0). Evaluation of the sta-
tistical significance was done by means of the variance analysis
(ANOVA) followed by post hoc Student-Newman-Keuls testing.
The 5% level (p < 0.05) was adopted as the significance criterion.3. Results
3.1. Effects on the oxidative state of arthritic rats
3.1.1. Plasma
Four parameters were measured in the plasma of control and
arthritic rats: the myeloperoxidase activity (MPO), the protein thiol
levels, the protein carbonyl levels (PC) and the antioxidant capacity
(FRAP). The results are shown in Fig. 1. The myeloperoxidase activ-Fig. 2. Treatment of normal and arthritic rats with the grape pomace extract: effects on li
for the assays, as described in Section 2. Values represent the mean ± standard error of th
the same symbol on each graph do not differ statistically from each other (p < 0.05) ac
Legends: PC, protein carbonyls; ROS, reactive oxygen species.ity (panel A), which can be regarded as an indicator for both the
oxidative and inflammatory states (Kothari et al., 2011), was not
modified when control (healthy) rats were treated with the grape
pomace extract. Arthritis, on the other hand, more than doubled
the myeloperoxidase activity (2.5-fold), but the grape pomace
treatment totally prevented this increase. The protein thiol groups
were 59% diminished by arthritis (panel B). In this case the grape
pomace treatment was without significant effects on both healthy
and arthritic rats. The protein carbonyls content (panel C), an
indicative of protein damage, was increased by arthritis (41%).
Treatment with the grape pomace did not affect this parameter
in healthy rats, but it prevented in full the protein damage in
arthritic rats. The evaluation of the antioxidant capacity in the
plasma, estimated as the ferric ion antioxidant reducing power, is
shown in panel D of Fig. 1. Grape pomace treatment did not
increase the antioxidant capacity of healthy rats. Arthritis, on the
other hand, clearly impaired the antioxidant capacity by 36%. This
impairment, however, was prevented by the grape pomace
treatment.
3.1.2. Liver and brain
Protein damage in both liver and brain were estimated as the
tissue content of protein carbonyl groups. The results are shown
in panels A and B of Fig. 2 (PC). Corroborating previous results,
arthritis increased protein damage in both tissues, 55% in the liverver and brain oxidative stress indicators. Freeze-clamped tissues were homogenized
e mean from 4 to 6 animals for each experimental condition. Columns labeled with
cording to one-way ANOVA followed by Student-Newman-Keuls post hoc testing.
G.A. Gonçalves et al. / Journal of Functional Foods 33 (2017) 408–418 413and 51% in the brain. Treatment with the grape pomace prevented
protein damage caused by arthritis in both tissues, but did not
modify the protein carbonyl levels in healthy rats.
The levels of reactive oxygen species (ROS), estimated by means
of the traditional 20,70-dichlorofluorescein-diacetate assay, are
shown in panels C and D of Fig. 2. No modifications were seen in
healthy rats treated with the grape pomace extract. As expected
from previous reports, arthritis caused a quite pronounced increase
of 164% in the ROS levels of the liver and a less pronounced
increase of 60% in the brain. Treatment of arthritic rats with the
grape pomace extract partly prevented the rise in the ROS levels.
In the liver, treated arthritic rats still presented increased ROS
levels, but only 59.5% above the control levels, what represents a
diminution of 64%. In the brain the ROS level of treated arthritic
rats was not significantly different from that of the control rats.
Two antioxidant enzymes were assayed in both liver and brain,
namely superoxide dismutase (SOD) and catalase (CAT). The
results are shown in Fig. 3. No clear diminution of the superoxide
dismutase activity (SOD) in the liver homogenate of arthritic rats
was found (panel A), although a diminishing tendency was appar-
ent, without statistical significance, however. Similarly, the effects
of the grape pomace extract treatment did not present statistical
significance. In the brain, however, arthritis clearly diminishedFig. 3. Treatment of normal and arthritic rats with the grape pomace extract: effects on
the assays, as described in Section 2. Values represent the mean ± standard error of the m
symbol on each graph do not differ statistically from each other (p < 0.05) according to on
superoxide dismutase; CAT, catalase.the SOD activity by 61% (panel B). The grape pomace treatment
prevented this diminution without affecting the activity in healthy
rats. Arthritis diminished the CAT activity in the liver by 77% (panel
C). This pronounced decrease was not prevented by the grape
pomace treatment, although a tendency in this direction was
apparent. The diminution of the CAT activity in the brain of
arthritic rats was less pronounced than in the liver (35%) and the
dispersion of the data do not allow to conclude in favour of an
effective prevention of this diminution by the grape pomace
extract (panel D).
The results of the GSH and GSSG measurements in liver and
brain are shown in Table 1. The sum of the GSH + GSSG contents
(expressed in GSH units) and the GSH/GSSG ratios were also calcu-
lated. In agreement with previous reports arthritis diminished the
GSH levels in both liver (42%) and brain (36%) (Comar et al., 2013;
Wendt et al., 2015). The grape pomace treatment attenuated these
decreases in both tissues. The GSSG levels were somewhat
increased by arthritis in the brain, a phenomenon prevented by
the grape pomace treatment. Decrease in GSH and increase in GSSG
also leads to decreased GSH/GSSG ratios, which can be regarded as
redox indicators for the NADP+/NADPH systems of each tissue. This
phenomenon, more pronounced in the brain, was also prevented
by the grape pomace treatment.liver and brain antioxidant enzymes. Freeze-clamped tissues were homogenized for
ean from 6 animals for each experimental condition. Columns labeled with the same
e-way ANOVA followed by Student-Newman-Keuls post hoc testing. Legends: SOD,
Table 1
Effects of arthritis and grape pomace extract treatment on the contents of GSH and GSSG in liver and brain.
Parameters Tissue Control Treated control Arthritic Treated arthritic
GSH (nmol/mg) Liver 15.71 ± 1.74a (n = 4) 17.47 ± 0.74a (n = 4) 9.09 ± 1.48b (n = 4) 13.43 ± 0.55a (n = 4)
Brain 7.91 ± 0.79a,c (n = 6) 9.90 ± 0.91c (n = 6) 5.04 ± 0.34b (n = 6) 7.30 ± 0.55a (n = 6)
GSSG (nmol/mg) Liver 1.75 ± 0.03a (n = 4) 1.77 ± 0.09a (n = 4) 1.76 ± 0.04a (n = 4) 1.78 ± 0.05a (n = 4)
Brain 0.64 ± 0.06a (n = 6) 0.68 ± 0.07a (n = 6) 0.96 ± 0.04b (n = 6) 0.73 ± 0.05a (n = 6)
GSH + 2  GSSG (nmol GSH units/mg) Liver 19.21 ± 1.76a (n = 4) 21.0 ± 0.91a (n = 4) 12.60 ± 1.43b (n = 4) 17.01 ± 0.65a (n = 4)
Brain 9.42 ± 0.89a,c (n = 5) 11.80 ± 0.91b (n = 5) 6.95 ± 0.29c (n = 5) 8.40 ± 0.38c (n = 6)
GSH/GSSG Liver 8.15 ± 0.57a (n = 4) 9.91 ± 0.20c (n = 4) 5.21 ± 0.89b (n = 4) 7.75 ± 0.24a (n = 4)
Brain 15.36 ± 1.09a (n = 5) 14.00 ± 1.58a,c (n = 6) 5.60 ± 0.23b (n = 5) 11.21 ± 1.09c (n = 6)
Control and arthritic rats were treated with the aqueous extract of grape pomace (250 mg/kg) according to the experimental protocol described in Section 2. The data
represent the mean ± standard error. Values with the same superscript in the same line do not differ statistically from each other (p  0.05) according to one-way ANOVA
followed by Student-Newman-Keuls post hoc testing.
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The development of arthritis was assessed by measuring the
edema formation after adjuvant injection in the posterior paws.
The results obtained with non-treated rats and with grape
pomace-treated and ibuprofen-treated rats (positive controls) are
shown in Fig. 4. The sequence of events in Fig. 4 can be best inter-
preted when analyzed together with the sequence of experimental
procedures illustrated by Fig. 1A in Appendix A. An inflammatory
reaction in the injected paw was observed on the first day post-
adjuvant injection (panel A). After the initial increase in the first
day the volume of the injected paw further increased progressively
up to day 18. Ibruprofen reduced this increase by 37%. The grape
pomace treatment also reduced the edema formation in the
injected paw, but the effect was less pronounced and at day 18
the edema volume was 19% under the control. The inflammatory
response in the non-injected paw started at day 10 and progressed
further thereafter (panel B). Here the effect of ibruprofen was moreFig. 4. Effects of the and grape pomace (250 mg/kg) extract and ibuprofen treatments (
injection. A: volume increase of the injected paw (left hind paw); B: volume increase of th
tail). Details are given in Sections 2.11 and 2.12. Each point represents the mean ± SEM of
arthritic animals.pronounced, with 53% inhibition. The grape pomace extract, on the
other hand, reduced the edema in the non-injected paw by 29%.
The appearance of the secondary lesions, as shown in Fig. 4C,
was considerably delayed by the grape pomace extract, but after
day 14 they reached at once the levels found in the non-treated
rats. A similar delay in the appearance and development of sec-
ondary lesions was observed in ibuprofen injected rats and the
score still was under the arthritic control levels at day 18.
Leukocyte migration into the knee cartilages is a well known
phenomenon that accompanies arthritis in both patients and
adjuvant-induced arthritic rats (Wright, Moots, Bucknall, &
Edwards, 2010). In the present study the influence of the grape
pomace extract treatment on the infiltration of mono- and poly-
morphonucelar leukocytes in the right and left femoro-tibial joint
cavities of the legs was evaluated at day 18 after arthritis induc-
tion. The results are summarized in Table 2. As expected, arthritis
greatly increased the infiltration of leukocytes in both joint cavi-
ties. Treatment with ibuprofen or with the grape pomace extract35 mg/kg) on the development of the inflammatory response to Freund’s adjuvant
e non-injected paw (right hind paw); C: secondary lesions score (ears, front legs and
5 animals. Asterisks indicate statistical significance (p < 0.05) relative to the control
Table 2
Effects of the grape pomace extract and ibuprofen treatments on the leukocyte counts of the right and left the femoro-tibial joint cavities of adjuvant-induced arthritic rats.
Groups 18 days after injection CFA (cells/mm3)
Right femoro-tibial joint cavity Left femoro-tibial joint cavity
Mononuclear leukocytes Polymorphonuclear leukocytes Mononuclear leukocytes Polymorphonuclear leukocytes
Control 1.85 ± 0.06 0.44 ± 0.02 0.88 ± 0.12 0.32 ± 0.01
Arthritic 84.93 ± 8.43a 274.11 ± 31.67 138.75 ± 21.26b 329.01 ± 59.13
Arthritic + ibuprofen 118.09 ± 15.10a 70.39 ± 14.09 170.30 ± 19.84b 114.50 ± 18.11c
Arthritic + grape pomace 105.79 ± 3.48a 158.73 ± 4.99 194.97 ± 5.59b 183.59 ± 9.75c
Arthritic rats were treated with ibuprofen (35 mg/kg) and with the aqueous extract of grape pomace (250 mg/kg) according to the experimental protocols described in
Section 2. The data represent the mean ± standard errors of the means from 3 to 5 animals. Values labeled in the same column with the same letter do not differ statistically
from each other (p < 0.05) according to one-way ANOVA followed by Student-Newman-Keuls post hoc testing.
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contrary, there was even a tendency of increasing the infiltration of
these cells, with no statistical significance, however. The infiltra-
tion of polymorphonuclear leukocytes, on the other hand, was
diminished by both ibuprofen and grape pomace extract treat-
ments. The diminution caused by the grape pomace extract treat-
ment was similar in both right and left femoro-tibial joint
cavities, more specifically 42 and 44%. For comparison, the diminu-
tions caused by the ibuprofen treatment ranged 74 and 65% in the
right and left femoro-tibial joint cavities, respectively.3.3. Chemical composition of the grape pomace extract
The characterization of the non-anthocyanins and anthocyanin
compounds present in the grape pomace was performed by HPLC-
DAD-MS analysis, and data regarding the retention time, kmax,
pseudomolecular ion, main fragment ions in MS2, tentative identi-
fication and quantification of phenolic compounds are presented in
Table 3 (non-anthocyanin compounds) and Table 4 (anthocyanin
compounds). The HPLC phenolic profiles of the grape pomace
recorded at 280, 370 and 520 nm are shown in Fig. 2A in Appendix
A, where the peaks were labeled with the same numbers as in
Tables 3 and 4. Up to 25 phenolic compounds were identified, cor-
responding to nine flavan-3-ols derivatives, three galloyl deriva-Table 3
Retention time (Rt), wavelengths of maximum absorption in the visible region (kmax),
compounds in the Merlot hydroalcoholic extract.
Non-anthocyanin compounds
Compounds Rt (min) kmax (nm) [MH] (m/z) MS2 (m/z)
1 4.68 280 325 169(100), 125(8)
2 5.6 280 577 451(23), 425(100), 407(22),
3 5.74 267 495 343(100), 191(8), 169(3)
4 6.3 280 577 451(23), 425(100), 407(22),
5 7.16 280 289 245(100), 203(50), 187(10),
6 7.62 280 577 451(23), 425(100), 407(22),
7 7.94 280 577 451(23), 425(100), 407(22),
8 8.57 278 477 325(100), 169(3), 125(2)
9 9.65 280 289 245(100), 203(35), 187(6), 1
10 11.06 279 865 739(78), 713(47), 695(100),
425(12), 407(9), 289(6), 287
11 11.1 279 865 739(78), 713(47), 695(100),
425(12), 407(9), 289(6), 287
12 12.3 280 1153 865(25), 739(78), 713(47), 6
575(42), 425(12), 407(9), 28
13 15.61 350 479 317(100)
14 18.4 350 477 301(100)
15 19.3 350 463 301(100)
16 19.6 350 493 331(100)
17 21.56 349 433 301(100)
18 22.52 348 447 301(100)
19 23.49 350 477 315(100)
20 24.36 351 655 509(15), 501(49), 475(63), 3
Total non-anthocyanin comtives, eight flavonols derivatives and five anthocyanins
derivatives. The same family of compounds has been also identi-
fied by Rodriguez-Rodriguez et al. (2012).
Flavan-3-ols (i.e., catechins and proanthocyanidins) were the
most relevant flavonoids found in the grape pomace extract (com-
pounds 2, 4–7 and 9–12; Table 3). Compounds 5 and 9 were iden-
tified as (+)-catechin and ()-epicatechin by comparison of their
UV and MS spectra as also the retention time with commercial
standards. Compounds 2, 4, 6 and 7 presented the same pseudo
molecular ion [MH] at m/z 577 and MS2 fragmentation patterns
coherent with B-type (epi)catechin dimers (i.e., (epi)catechin units
with C4–C8 or C4–C6 interflavan linkages). Characteristic product
ions were observed at m/z 451 (126 mu), 425 (152 mu) and
407 (152–18 mu), attributable to the HRF, RDA and further loss
of water from an (epi)catechin unit, and at m/z 289 and 287, that
could be associated to the fragments corresponding to the lower
and upper (epi)catechin unit, respectively. These compounds, espe-
cially peak 2, were the most abundant compounds present in the
samples. Other signals at m/z 865 (peaks 10 and 11) and 1153
(peak 12) were associated to B-type procyanidin trimers and tetra-
mers, respectively.
Compounds 1, 3 and 8 were identified as galloyl derivatives, due
to their MS fragmentation pattern and UV–vis spectra. Compound
1 presented the pseudo molecular ion [MH] at m/z 325,mass spectrometric data, and tentative identification of non-anthocyanin phenolic
Tentative identification Quantity (mg/g)
Galloylshikimic acid 3.37 ± 0.04
289(12), 287(10) B-type (epi)catechin dimer 10.2 ± 0.2
Digalloylquinic acid 2.30 ± 0.01
289(12), 287(10) B-type (epi)catechin dimer 6.7 ± 0.2
161(9), 137(3) (+)-Catechin 7.27 ± 0.12
289(12), 287(10) B-type (epi)catechin dimer 3.2 ± 0.1
289(12), 287(10) B-type (epi)catechin dimer 5.33 ± 0.02
Digalloylshikimic acid 1.88 ± 0.03
61(8), 137(3) ()-Epicatechin 7.3 ± 0.3
577(62), 575(42),
(11)
B-type (epi)catechin trimer 4.9 ± 0.1
577(62), 575(42),
(11)
B-type (epi)catechin trimer 3.6 ± 0.1
95(100), 577(62),
9(6), 287(11)
B-type (epi)catechin tretramer 6.2 ± 0.3
Myricetin-O-hexoside 1.42 ± 0.01
Quercetin-3-O-glucuronide 0.56 ± 0.02
Quercetin-3-O-glucoside 0.52 ± 0.01
Laricitrin-O-hexoside 0.36 ± 0.02
Quercetin-O-pentoside 0.40 ± 0.01
Quercetin-O-rhamnoside 0.38 ± 0.01
Isorhamnetin-3-O-glucoside 0.51 ± 0.01
47(20), 329(100), 314(13) Methylisorhamnetin derivative 0.31 ± 0.01
pounds 66.6 ± 0.7
Table 4
Retention time (Rt), wavelengths of maximum absorption in the visible region (kmax), mass spectrometric data, and tentative identification of anthocyanin phenolic compounds in
the Merlot hydroalcoholic extract.
Anthocyanin compounds
Compounds Rt (min) kmax (nm) [M+H]+ (m/z) MS2 (m/z) Tentative identification Quantity (mg/g)
21 40.1 520 479 317(100) Petunidin-3-O-glucoside 0.592 ± 0.001
22 43.2 520 463 301(100) Peonidin-3-O-glucoside 1.555 ± 0.002
23 44.2 520 493 331(100) Malvidin-3-O-glucoside 3.407 ± 0.001
24 53.3 520 505 301(100) Peonidin-3-O-acetylglucoside 0.694 ± 0.001
25 53.8 520 535 331(100) Malvidin-3-O-acetylglucoside 0.740 ± 0.001
Total anthocyanin compounds 6.988 ± 0.003
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a shikimic acid moiety), being tentatively identified as a galloyl-
shikimic acid. Similarly, compound 8 ([MH] at m/z 477) was
associated to a digalloylshikimic acid. Furthermore, compound 3
presented a pseudomolecular ion [MH] at m/z 495 showing
three MS2 fragments, one at m/z 343 ([M152H], loss of a gal-
loyl group), another at m/z 191, related to the elimination of the
second galloyl moiety (152 m) and corresponding to quinic acid
and finally the formation of the deprotonated gallic acid at m/z
169. This compound was identified as digalloylquinic acid.
Compounds 13–20 were identified as flavonols, especially quer-
cetin, myricetin, laricitrin (30-O-methylmyricetin) and isorham-
netin glycoside derivatives. Compounds 14, 15,17 and 18
presented pseudomolecular ions [MH] at m/z 477, 463, 433
and 447 releasing an MS2 fragment at m/z 301 (176 m, 162 m,
132 m and 146 m, corresponding to the losses of glucuronyl, glu-
cosyl, pentosyl and rhamnosyl moieties, respectively); these com-
pounds were identified as quercetin-3-O-glucuronide, quercetin-3-
O-glucoside (by comparison with commercial standards),
quercetin-O-pentoside and quercetin-O-rhamnoside, respectively.
Compounds 13 ([MH] at m/z 479), 16 ([MH] at m/z 493)
and 19 ([MH] at m/z 477) were assigned to a myricetin-O-
hexoside, laricitrin-O-hexoside and isorhamnetin-3-O-glucoside
according to its UV and mass fragmentation pattern and in the case
of the last compounds with comparison with commercial stan-
dards. Finally, it was not possible to achieve an identification for
compound 20 ([MH] atm/z 479) which was tentatively assigned
as a methyl isorhamnetin derivative.
The anthocyanin compounds (peaks 21–25 in Table 4) were
identified taking into account the identifications performed by
Kammerer, Kljusuric, Carle, and Schieber (2005), being identified
as petunidin glycoside derivative (peak 20), peonidin glycoside
derivatives (peaks 22 and 24) and malvidin (peaks 23 and 25).
The most abundant compound present in grape pomace extract
was malvidin-3-O-glucoside, as also described by Kammerer
et al. (2005).4. Discussion
4.1. Antioxidant action
This study presents experimental evidence that components of
an hydroalcoholic extract of the Merlot grape pomace are able to
attenuate the modifications in the oxidative state caused by arthri-
tis. Several oxidative stress indicators in arthritic rats were main-
tained at their normal or closely normal levels by the grape
pomace treatment in the plasma, liver and brain. The list comprises
protein damage in the plasma and the ROS levels and protein dam-
age in both brain and liver. Furthermore, the grape pomace extract
was also capable of maintaining the normal levels of the antioxi-
dant capacity in the plasma as well as in the liver and brain. For
the first compartment this is indicated by a direct measurementof the antioxidant capacity (FRAP) and for the liver and brain
mainly by the GSH levels. The concomitant and coherent action
in three compartments of the body suggests that a similar action
can be expected to occur in all tissues and organs.
The same model of adjuvant induced arthritis in rats was used
in previous studies to demonstrate the improvement of the oxida-
tive state by a tamarind seed extract (Sundaram et al., 2014) and a
green-tea extract (Gonçalves et al., 2015). Both extracts exert
almost the same effects as the Merlot grape pomace extract used
in the present study. The differences are mainly quantitative. With
respect to the green tea extract, for example, it was more effective
in preserving the reduced thiols levels in the plasma whereas a
mere tendency in this direction was observed with the grape
pomace (Fig. 1B). The same applies to the catalase activities in both
liver and brain. It should be noted that the Merlot grape pomace
did not modify the oxidative state of healthy rats. This is consistent
with a study in which the action of Norton grape pomace treat-
ment did not modify the oxidative state of diet induced obese mice
in which the oxidative stress markers remained within the normal
range (Hogan et al., 2010). Protection against CCl4-induced hepatic
injury was also demonstrated for a methanolic grape pomace
extract, which was able to restore the activity of several enzymes
and to prevent lipid peroxidation (Murthy, Singh, & Jayaprakasha,
2002).
4.2. Anti-inflammatory action
An anti-inflammatory action was also demonstrated for the
grape pomace extract. This conclusion is allowed by the observa-
tions that the grape pomace treatment was able to delay and to
diminish the development of the paw edema in adjuvant-
injected rats. Delay of the appearance of secondary lesions is a fur-
ther indicator of an anti-inflammatory action. Moreover, the grape
pomace treatment was also able to diminish the infiltration of
polymorphonuclear leukocytes (neutrophiles) in the femoro-
tibial joint cavities of the legs, with an effectiveness that was not
very far from that observed with ibuprofen at the administered
doses (Dancevic, Daniel, & McCulloch, 2014). Consistently, the
grape pomace treatment was equally able to diminish the
myeloperoxidase activity in the plasma. The level of this enzyme
is usually regarded as a marker of the neutrophil proliferation
and severity of inflammation (Kothari et al., 2011). Inhibition of
neutrophile infiltration can be important because these cells are
responsible for the production of several agents able to cause tis-
sue damage such as proteases and cytokines (Kothari et al., 2011).
The observed anti-inflammatory effects of the Merlot grape
pomace extract is in accordance with a few similar observations.
Norton grape pomace treatment, for example, attenuated inflam-
mation in diet-induced obese mice, as indicated by a 15.5%
decrease in the C-protein levels (Hogan et al., 2010). An anti-
inflammatory action was also demonstrated for the Petit Verdot
grape pomace and the red grape pomace (Denny et al., 2014;
Nishiumi, Mukai, Ichiynagi, & Ashida, 2012). Treatment of mice
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effective in diminishing the carrageenan induced paw edema and
the inflammatory cytokine levels in the peritoneal cavity (Denny
et al., 2014). The anti-inflammatory action of the red grape-
pomace was indicated by the supression of the LPS/GalN-induced
activation of the factor nuclear kappa B and expression of the indu-
cible nitric oxide synthase and cyclooxygenase-2 proteins
(Nishiumi et al., 2012).
4.3. Compounds involved
The grape pomace extract that was given daily to the rats dur-
ing 23 days in the present study was extensively scrutinized for its
content in phenolic compounds (Tables 3 and 4), which are proba-
bly involved in the antioxidant activity that was described. The
most abundant polyphenolics in the extract are catechin, epicate-
chin and derivatives. Several derivatives of quercetin and gallic
acid are also present. Quantification of the antioxidant capacity
of each compound varies considerably because several methods
have been used by several authors. However, by analyzing six dif-
ferent studies, catechin, gallic acid and quercetin are clearly among
the most effective ones as free radical scavengers (Iacopini, Baldi,
Storchi, & Sebastiani, 2008; Karamac, Kosin´ska, & Pegg, 2005;
Khanduja & Bhardawy, 2003; Kwon, Kim, Lee, & Kim, 2010; Lu,
Khoo, & Wiart, 2014; Weingerl, 2012). An important factor in addi-
tion to abundance and effectiveness as free-radical scavengers is
bioavailability. Concerning this subject, a compilation of pharma-
cokinetic data from 97 bioavailability studies in humans concluded
that gallic acid is better absorbed than the other polyphenols, fol-
lowed by catechins and quercetin glucosides (Manach, Williamson,
Morand, Scalbert, & Rémésy, 2005). This combination of abundance
and good bioavailability, thus, reinforces again the importance of
catechin and its derivatives in the grape pomace extract used in
the present study. As a group, the anthocyanin compounds are rel-
atively abundant in the grape pomace extract (Table 3). Although
several of them may have a medium or even strong antioxidant
activity (Kähkönen & Heinonen, 2003), their bioavailability is usu-
ally not very pronounced (Manach et al., 2005). In consequence
their contribution to the overall antioxidant effects observed in
the present work is possibly less important.
It is also likely that the catechin and epichatechin derivatives
found in the Merlot hydroalcoholic extract may be involved in
the anti-inflammatory activity. In this respect, there are reports
of anti-inflammatory activity exerted by pure or nearly pure prepa-
rations of catechin and epichatechin derivatives. It was shown, for
example, that (-)epigallocatechin-3-gallate suppresses osteoclast
differentiation and ameliorates experimental arthritis in mice
(Morinobu et al., 2012). Another example is the prevention of
collagen-induced arthritis in mice, which was achieved by treat-
ment of these animals with a polyphenolic fraction of green tea
(Haqqi et al., 1999).
It must be remarked that attention of this work was focused on
the phenolic compounds in the grape pomace extract because a
possible effect on the oxidative stress that accompanies arthritis
was also the main objective of the present work. One cannot
exclude, however, that other compounds could be involved, espe-
cially in the anti-inflammatory effects that were also observed.
This is an aspect that certainly deserves attention in the future.
4.4. Concluding remarks
At least to our knowledge, this is one of the first studies analyz-
ing in detail the effects of a grape pomace extract in arthritic ani-
mals. The results suggest a potential applicability of the Merlot
grape pomace hydroalcoholic extract in the improvement of the
oxidative and inflammatory states in arthritic patients. For use infood supplements, the grape pomaces have the advantage of being
abundant and relatively inexpensive (Fontana, Antoniolli, & Bottini,
2013). It should be stressed, however, that our results apply specif-
ically to the Merlot grape pomace as the composition of the grape
pomaces varies considerably among the various cultivars (Ribeiro
et al., 2015). On the other hand, it would be of interest to investi-
gate if the grape pomace treatment is equally able to prevent the
metabolic modifications that are associated to arthritis which,
especially in the liver, lead to modifications in important metabolic
pathways such as glycolysis, gluconeogenesis and ureogenesis as
well as in the calcium homeostasis (Fedatto-Jr et al., 1999, 2000;
Utsunomiya et al., 2013; Yassuda-Filho et al., 2003).Disclosure statement
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